Kabra Drugs Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 35.52 | 30.60 | 19.94 |
| Operating Expense | 34.07 | 27.99 | 17.73 |
| Net Profit | 1.06 | 2.57 | 1.84 |
| Net Profit Margin | 2.98% | 8.40% | 9.23% |
| Earning Per Share | 0.45 | 1.08 | 0.77 |
| EBIDTA | 1.45 | 2.61 | 2.22 |
| Effective Tax Rate | 24.83% | 1.15% | 16.67% |
Particulars
Mar 2026
Revenue35.52
Operating Expense34.07
Net Profit1.06
Net Profit Margin2.98
Earning Per Share0.45
EBIDTA1.45
Effective Tax Rate24.83
